Squaric Acids: A New Motif for Designing Inhibitors of Protein Tyrosine Phosphatases

Organic Letters

Volumn 6, Issue 1, 2004, Pages 83-86

  Xie, Jian ^a   Comeau, Anthony B ^a   Seto, Christopher T ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE INHIBITOR; SQUARIC ACID DERIVATIVE;

ARTICLE; BACTERIAL INFECTION; DRUG DESIGN; NON INSULIN DEPENDENT DIABETES MELLITUS; YERSINIA PESTIS;

AMIDES; CYCLOBUTANES; DRUG DESIGN; ENZYME INHIBITORS; HUMANS; MODELS, CHEMICAL; MOLECULAR STRUCTURE; PROTEIN-TYROSINE-PHOSPHATASE;

EID: 0742321835     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol036121w     Document Type: Article

References (38)

1. For a recent review, see: Hooft van Huijsduijnen, R.; Bombrun, A.; Swinnen, D. Drug Discov. Today 2002, 7, 1013-1019.
2. For a recent review, see Johnson, T. O.; Ermolieff, J.; Jirousek, M. R. Nat. Rev. Drug Discov. 2002, 1, 696-709.
3. Harder, K. W.; Moller, N. P. H.; Peacock, J. W.; Jirik, F. R. J. Biol. Chem. 1998, 273, 31890-31900.
4. (a) Lazo, J. S.; Nemoto, K.; Pestell, K. E.; Cooley, K.; Southwick, E. C.; Mitchell, D. A.; Furey, W.; Gussio, R.; Zaharevitz, D. W.; Joo, B.; Wipf, P. Mol. Pharmacol. 2002, 61, 720-728.
5. (b) Galaktionov, K.; Lee, A. K.; Eckstein, J.; Draetta, G.; Meckler, J.; Loda, M.; Beach, D. Science 1995, 269, 1575-1577.
6. Penninger, J. M.; Irie-Sasaki, J.; Sasaki, T.; Oliveira-dos-Santos, A. J. Nat. Immunol. 2001, 2, 389-396.
7. DeVinney, R.; Steele-Mortimer, O.; Finlay, B. B. Trends Microbiol. 2000, 8, 29-33.
8. For reviews, see: (a) Burke, T. R., Jr.; Zhang, Z.-Y. Biopolymers 1998, 47, 225-241. (b) Burke, T. R., Jr.; Yao, Z.-J.; Liu, D.-G.; Voigt, J.; Gao, Y. Biopolymers 2001, 60, 32-44. (c) Ripka, W. C. Annu. Rep. Med. Chem. 2000, 35, 231-250.
9. For reviews, see: (a) Burke, T. R., Jr.; Zhang, Z.-Y. Biopolymers 1998, 47, 225-241. (b) Burke, T. R., Jr.; Yao, Z.-J.; Liu, D.-G.; Voigt, J.; Gao, Y. Biopolymers 2001, 60, 32-44. (c) Ripka, W. C. Annu. Rep. Med. Chem. 2000, 35, 231-250.
10. For reviews, see: (a) Burke, T. R., Jr.; Zhang, Z.-Y. Biopolymers 1998, 47, 225-241. (b) Burke, T. R., Jr.; Yao, Z.-J.; Liu, D.-G.; Voigt, J.; Gao, Y. Biopolymers 2001, 60, 32-44. (c) Ripka, W. C. Annu. Rep. Med. Chem. 2000, 35, 231-250.
11. (a) Groves, M. R.; Yao, Z.-J.; Roller, P. P.; Burke, T. R., Jr.; Barford, D. Biochemistry 1998, 37, 17773-17783.
12. (b) Shen, K.; Keng, Y.-F.; Wu, L.; Guo, X.-L.; Lawrence, D. S.; Zhang, Z.-Y. J. Biol. Chem. 2001, 276, 47311-47319.
13. Burke, T. R., Jr.; Ye, B.; Akamatsu, M.; Ford, H., Jr.; Yan, X.; Kole, H. K.; Wolf, G.; Shoelson, S. E.; Roller, P. P. J. Med. Chem. 1996, 39, 1021-1027.
14. Andersen, H. S.; Iversen, L. F.; Jeppesen, C. B.; Branner, S.; Norris, K.; Rasmussen, H. B.; Moller, K. B.; Moller, N. P. H. J. Biol. Chem. 2000, 275, 7101-7108.
15. Leung, C.; Grzyb, J.; Lee, J.; Meyer, N.; Hum, G.; Jia, C.; Liu, S.; Taylor, S. D. Bioorg. Med. Chem. 2002, 10, 2309-2323.
16. Larsen, S. D.; Stevens, F. C.; Lindberg, T. J.; Bodnar, P. M.; O'Sullivan, T. J.; Schostarez, H. J.; Palazuk, B. J.; Bleasdale, J. E. Bioorg. Med. Chem. Lett. 2003, 13, 971-975.
17. (a) Chen, Y. T.; Onaran, M. B.; Doss, C. J.; Seto, C. T. Bioorg. Med. Chem. Lett. 2001, 11, 1935-1938.
18. (b) Chen, Y. T.; Seto, C. T. J. Med. Chem. 2002, 45, 3946-3952.
19. (c) Chen, Y. T.; Xie, J.; Seto, C. T. J. Org. Chem. 2003, 68, 4123-4125.
20. See Supporting Information for a comparison of electron density calculations of phenyl phosphate dianion and 2-phenyl-1-hydroxycyclobut-1-ene-3, 4-dione monoanion.
21. a of 2-phenyl-1-hydroxycyclobut-1-ene-3,4-dione has been reported as 0.37 or -0.22. (a) Smutney, E. J.; Caserio, M. C.; Roberts, J. D. J. Am. Chem. Soc. 1960, 82, 1793-1801. (b) Patton, E.; West, R. J. Am. Chem. Soc. 1973, 95, 8703-8707.
22. a of 2-phenyl-1-hydroxycyclobut-1-ene-3,4-dione has been reported as 0.37 or -0.22. (a) Smutney, E. J.; Caserio, M. C.; Roberts, J. D. J. Am. Chem. Soc. 1960, 82, 1793-1801. (b) Patton, E.; West, R. J. Am. Chem. Soc. 1973, 95, 8703-8707.
23. Douglas, K. T.; Nadvi, I. N. FEBS Lett. 1979, 106, 393-396.
24. Burka, L. T.; Doran, J.; Wilson, B. J. Biochem. Pharmacol. 1982, 31, 79-84.
25. Sato, K.; Seio, K.; Sekine, M. J. Am. Chem. Soc. 2002, 124, 12715-12724.
26. Beaulieu, P. L.; Cameron, D. R.; Ferland, J.-M.; Gauthier, J.; Ghiro, E. ; Gillard, J.; Gorys, V.; Poirier, M.; Rancourt, J.; Wernic, D.; Llinas-Brunet, M.; Betageri, R.; Cardozo, M.; Hickey, E. R.; Ingraham, R.; Jakes, S.; Kabcenell, A.; Kirrane, T.; Lukas, S.; Patel, U.; Proudfoot, J.; Sharma, R.; Tong, L.; Moss, N. J. Med. Chem. 1999, 42, 1757-1766.
27. Chan, P. C. M.; Roon, R. J.; Koerner, J. F.; Taylor, N. J.; Honek, J. F. J. Med. Chem. 1995, 38, 4433-4438.
28. Kinney, W. A.; Abou-Gharbia, M.; Garrison, D. T.; Schmid, J.; Kowal, D. M.; Bramlett, D. R.; Miller, T. L.; Tasse, R. P.; Zaleska, M. M.; Moyer, J. A. J. Med. Chem. 1998, 41, 236-246.
29. Keil, D.; Hartmann, H. Dyes Pigments 2001, 49, 161-179.
30. Ohno, M.; Yamamoto, Y.; Shirasaki, Y.; Eguchi, S. J. Chem. Soc., Perkin Trans. 1 1993 263-271.
31. Liu, H.; Tomooka, C. S.; Moore, H. W. Synth. Commun. 1997, 27, 2177-2180.
32. Liebeskind, L.; Bombrun, A. J. Org. Chem. 1994, 59, 1149-1159.
33. Schmidt, A. H.; Schmitt, G.; Diedrich, H. Synthesis 1990, 579-582.
34. Chen, Y.-Z.; Li, J.-C.; Huang, F.; Chen, L.-Y. Youji Huaxue 1998, 18, 130-136.
35. See Supporting Information.
36. PTPase inhibitors often show a decrease in potency with increasing pH. See, for example: Andersen, H. S.; Olsen, O. H.; Iversen, L. F.; Sorensen, A. L.; Mortensen, S. B.; Christensen, M. S.; Branner, S.; Hansen, T, K.; Lau, J. F.; Jeppesen, L.; Moran, E.; Su, J.; Bakir, F.; Judge, L.; Shahbaz, M.; Collins, T.; Vo, T.; Newman, M. J.; Ripka, W. C.; Moller, N. P. H. J. Med. Chem. 2002, 45, 4443-4459.
37. Salmeen, A.; Andersen, J. N.; Myers, M. P.; Tonks, N. K.; Barford, D. Mol. Cell 2000, 6, 1401-1412.
38. Stuckey, J. A.; Schubert, H. L.; Fauman, E. B.; Zhang, Z.-Y.; Dixon, J. E.; Saper, M. A. Nature 1994, 370, 571-575.